Lantern Pharma Inc (LTRN) insider trading
Every open-market stock purchase and sale by Lantern Pharma Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: D Jeffrey Keyser (Director), n/a, 5 months ago.
Last 12 months: insiders bought $0 (2 buys) and sold $0 (0 sales).
Recent LTRN insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 12, 2026 | D Jeffrey Keyser (Director) | Bought | — |
| May 12, 2026 | Lee Troy Schalop (Director) | Bought | — |
| Jan 9, 2026 | Maria-Luisa Maccecchini (Director) | Bought (not open market) | — |
| Jan 9, 2026 | Lee Troy Schalop (Director) | Bought (not open market) | — |
| Jan 9, 2026 | David S. Silberstein (Director) | Bought (not open market) | — |
| Jan 9, 2026 | David S. Silberstein (Director) | Bought (not open market) | — |
| Jan 9, 2026 | Vijay Chandru (Director) | Bought (not open market) | — |
| Jan 9, 2026 | Lee Troy Schalop (Director) | Bought (not open market) | — |
| Jan 9, 2026 | D Jeffrey Keyser (Director) | Bought (not open market) | — |
| Jan 9, 2026 | Maria-Luisa Maccecchini (Director) | Bought (not open market) | — |
| Jan 9, 2026 | D Jeffrey Keyser (Director) | Bought (not open market) | — |
| Jan 9, 2026 | Vijay Chandru (Director) | Bought (not open market) | — |
| Dec 18, 2025 | Kishor G. Bhatia (C-suite exec) | Bought (not open market) | — |
| Dec 18, 2025 | David R. Margrave (CFO) | Bought (not open market) | — |
Who's trading LTRN
- Lee Troy Schalop, Director: bought $0 (1 buy), last May 12, 2026
- D Jeffrey Keyser, Director: bought $0 (1 buy), last May 12, 2026
- David S. Silberstein, Director: other filings, last Jan 9, 2026
- Vijay Chandru, Director: other filings, last Jan 9, 2026
- Maria-Luisa Maccecchini, Director: other filings, last Jan 9, 2026
- Kishor G. Bhatia, C-suite exec: other filings, last Dec 18, 2025
- David R. Margrave, CFO: other filings, last Dec 18, 2025
Get free alerts when an insider at Lantern Pharma Inc files a new trade →